Evolus Inc (NASDAQ:EOLS)
| 9.76 Delayed Data As of Dec 01 |  +0.285 / +3.01%Today’s Change | 6.51 Today|||52-Week Range 11.49 | +29.89% Year-to-Date |
Latest EOLS News | Press Releases
No recent news for Evolus Inc.
Today’s Trading
| Previous close | 9.47 |
| Today’s open | 9.47 |
| Day’s range | 9.47 - 9.77 |
| Volume | 16,443 |
| Average volume (3 months) | 701,504 |
| Market cap | $557.2M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -41.12% |
| Earnings growth (this year) | +23.28% |
| Earnings growth (next 5 years) | +53.50% |
| Revenue growth (last year) | +49.10% |
| P/E ratio | NM |
| Price/Sales | 2.83 |
| Price/Book | 29.65 |
Competitors
| ---- | ||
| --Basilea Pharmaceutic... | 0.00 | 0.00% |
| PETQPetIQ Inc | +0.70 | +4.02% |
| ---- |
Data as of 4:00pm ET, 12/01/2023
Financials
| Next reporting date | February 28, 2024 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $148.6M |
| Annual profit (last year) | -$74.4M |
| Net profit margin | -50.07% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Newport Beach, California |
Forecasts
